PROS1 and COVID-19: Previously, due to the key role of the S protein in the process of viral invasion, several approved COVID-19 vaccines have been selected as the main immunogens from the S protein or its receptor binding domain (RBD) (Chen et al., 2021; Wang et al., 2021).